Print

Disclosure of Interests - Mark Bloch

Year*Type of relationshipEntityCommentPayment received
Board membership ViiV Healthcare; Gilead Sciences; Janssen; Boehringer-Ingelheim; Eli Lilly Yes
Consultancy MSD  HIV consultancy Yes
Grants / grants pending ViiV Healthcare; Abbvie; MSD; Janssen; Bristol Myers-Squibb Yes - Institution only
Payment for development of educational presentations including service on speaker' bureaus Eli Lilly Men's Health Yes
Payment for development of educational presentations including service on speaker' bureaus ViiV Healthcare HIV presentations Yes
Travel / accommodation expenses covered or reimbursed ViiV Healthcare; Gilead Sciences; MSD; Boehringer-Ingelheim; Bristol Myers-Squibb; Eli Lilly Travel to scientific meetings Yes


* Information provided for period of 36 months preceding 01 May 2013

Pfizer has discontinued the supply of FASIGYN (tinidazole) 500 mg tablet blister pack and SIMPLOTAN (tinidazole) 50… https://t.co/j44RNPsRSh

ASHM ASHM

#INHSU20 scholarship applications are currently open! Applications close Sunday 15 March 2020. Click here to apply:… https://t.co/3oRV5tuq9z

ASHM ASHM